Literature DB >> 20213099

Clinical investigation of malignant mesothelioma in Japan.

Nobukazu Fujimoto1, Keisuke Aoe, Kenichi Gemba, Katsuya Kato, Koichi Yamazaki, Takumi Kishimoto.   

Abstract

PURPOSE: The asbestos-related problems caused much social concern; however, no large-scale study was conducted about clinical features of MM in Japan. Patients with MM who have a history of occupational asbestos exposure (AE) are provided worker's compensation in Japan. However, only about 10% of MM cases were actually claimed and compensated. So there is still controversy over the association between MM and AE. The aim of this study is to investigate the clinical features of MM. We also aimed to clarify the association between MM and occupational AE in Japan.
METHODS: We examined the clinical features of MM cases. Clinical information was obtained including gender, age, site of origin, pathological subtype, radiological findings, and treatment outcome. To investigate the association between MM and AE, investigators interviewed all patients regarding work and residential history.
RESULTS: Between January 2005 and December 2007, 105 cases (median age: 63 years, range 35-80, male/female: 88/17) were diagnosed with MM in the Rosai Hospital group and related facilities. Among them, 94(89.5%) cases originated in the pleura, 7(6.7%) in the peritoneum, 2(1.9%) in the pericardium, and 1(0.9%) in the tunica vaginalis testis. There were 69(65.7%) epithelioid, 19(18.1%) biphasic, 16(15.2%) sarcomatoid, and 1 unclassified pathological subtypes of MM. A favorable survival rate was indicated in the patient group of MPM that underwent surgery compared to others, though it was not statistically significant (P = 0.1743). The occupational AE was indicated in 89 cases (84.8%). Three patients had no history of occupational AE, but lived with someone who was in an occupation that handled asbestos. There were two patients in which AE was indicated in their life environment. Altogether, AE was indicated in 93(88.6%) patients.
CONCLUSIONS: This study stresses the urgent need for physicians to acknowledge the association between MM and AE, and to inquire thoroughly regarding AE to the patients with MM.

Entities:  

Mesh:

Year:  2010        PMID: 20213099     DOI: 10.1007/s00432-010-0834-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.

Authors:  V W Rusch
Journal:  Lung Cancer       Date:  1996-02       Impact factor: 5.705

Review 3.  Advances in malignant mesothelioma.

Authors:  Bruce W S Robinson; Richard A Lake
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

4.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Authors:  D J Sugarbaker; R M Flores; M T Jaklitsch; W G Richards; G M Strauss; J M Corson; M M DeCamp; S J Swanson; R Bueno; J M Lukanich; E H Baldini; S J Mentzer
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

5.  Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area.

Authors:  M L Newhouse; H Thompson
Journal:  Br J Ind Med       Date:  1965-10

6.  Accuracy of pathological diagnosis of mesothelioma cases in Japan: clinicopathological analysis of 382 cases.

Authors:  Yukio Takeshima; Kouki Inai; Vishwa Jeet Amatya; Kenichi Gemba; Keisuke Aoe; Nobukazu Fujimoto; Katsuya Kato; Takumi Kishimoto
Journal:  Lung Cancer       Date:  2009-02-20       Impact factor: 5.705

7.  Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).

Authors:  B Castagneto; M Botta; E Aitini; F Spigno; D Degiovanni; O Alabiso; M Serra; A Muzio; R Carbone; R Buosi; V Galbusera; E Piccolini; L Giaretto; L Rebella; M Mencoboni
Journal:  Ann Oncol       Date:  2007-12-20       Impact factor: 32.976

8.  Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.

Authors:  Kei Kushitani; Yukio Takeshima; Vishwa Jeet Amatya; Osamu Furonaka; Akio Sakatani; Kouki Inai
Journal:  Pathol Int       Date:  2008-02       Impact factor: 2.534

9.  Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure.

Authors:  Takumi Kishimoto; Shinji Ozaki; Katsuya Kato; Hideyuki Nishi; Kenichi Genba
Journal:  Ind Health       Date:  2004-10       Impact factor: 2.179

10.  Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos.

Authors:  C Magnani; A Agudo; C A González; A Andrion; A Calleja; E Chellini; P Dalmasso; A Escolar; S Hernandez; C Ivaldi; D Mirabelli; J Ramirez; D Turuguet; M Usel; B Terracini
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

View more
  6 in total

1.  Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.

Authors:  Masanori Fujii; Nobukazu Fujimoto; Akio Hiraki; Kenichi Gemba; Keisuke Aoe; Shigeki Umemura; Hideki Katayama; Nagio Takigawa; Katsuyuki Kiura; Mitsune Tanimoto; Takumi Kishimoto
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

2.  Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy.

Authors:  Koji Nakashima; Haruhiko Inatsu; Kazuo Kitamura; Tomomi Hikosaka; Shinri Hoshiko; Shinya Ashiduka
Journal:  Clin J Gastroenterol       Date:  2012-10-17

Review 3.  Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure.

Authors:  Manuela Valenzuela; Margarita Giraldo; Sonia Gallo-Murcia; Juliana Pineda; Laura Santos; Juan Pablo Ramos-Bonilla
Journal:  Curr Environ Health Rep       Date:  2016-12

4.  Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients.

Authors:  Masashi Kobayashi; Cheng-Long Huang; Makoto Sonobe; Ryutaro Kikuchi; Masashi Ishikawa; Jiro Kitamura; Ryo Miyahara; Toshi Menju; Shotaro Iwakiri; Kazumi Itoi; Ryoji Yasumizu; Hiroshi Date
Journal:  Exp Ther Med       Date:  2012-03-12       Impact factor: 2.447

Review 5.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

6.  Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.

Authors:  Takehiro Otoshi; Yuki Kataoka; Shunkichi Ikegaki; Emiko Saito; Hirotaka Matsumoto; Sawako Kaku; Masatoshi Shimada; Masataka Hirabayashi
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.